Study: Hormone therapy may impact results of mammograms, biopsies

02/25/2008 | Forbes

A U.S. study found that patients who received combined hormone replacement therapy for about five years are more likely to have abnormal mammograms and breast biopsies compared with those who received a placebo. The findings suggest that HRT may affect the efficacy of the tests in breast cancer diagnosis. A doctor said women need to be more aware of the risks involved in HRT.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA